Stavudine/Lamivudine

司他夫定/拉米夫定

Report date: 2022/12/15 15:20:15

Base Information

Drug NameStavudine/Lamivudine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsReverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptaseReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/03/18
Country/TerritoryUnited States
CombinationsYes StavudineLamivudine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPharmacare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPharmacare Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A